ArticleBMC psychiatry2025
Can symptom-severity phenotypes identify depression risk after mild traumatic brain injury? A cluster-based approach.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04243226 (Develop and Rehabilitation Effects of the Safety Aerobic Exercise Prescription on Cognition, Depression and Quality of Life in Traumatic Brain Injury Patients- Taking the Cerebral Blood Circulation as a Mediator), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Develop and Rehabilitation Effects of the Safety Aerobic Exercise Prescription on Cognition, Depression and Quality of Life in Traumatic Brain Injury Patients- Taking the Cerebral Blood Circulation as a Mediator
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMild traumatic brain injury (mTBI) affects millions worldwide and frequently leads to secondary depression. Early identification of high-risk individuals is critical for targeted mental-health screening in this population. Data-driven phenotyping offers a promising avenue to unmask hidden symptom patterns, but few studies have combined unsupervised clustering of post-concussion profiles with established clinical and psychosocial metrics. We aimed to classify post-concussion symptom-severity profiles in adults with mTBI and to evaluate their association with secondary depression risk, adjusting for Glasgow Coma Scale (GCS) score, psychological resilience, age, sex, and time since injury.
methodsIn this cross-sectional analysis, 249 adults with mTBI (GCS 13-15) were recruited from a tertiary hospital in northern Taiwan. We performed hierarchical clustering using Ward's method with Euclidean distance (with BIC support) to derive three symptom-severity phenotypes from the Rivermead Post-Concussion Questionnaire items, then used k-means clustering to assign individuals to these by minizing within-cluster variance. Depression, defined as a Beck Depression Inventory-II ≥ 13, was modeled as an outcome in generalized linear models, adjusting for GCS and psychological resilience. Model discrimination was evaluated via area under the receiver operating characteristic curve (AUC).
resultsThree distinct symptom clusters (mild, moderate, severe) were identified. The severe cluster was characterized by prominent visual symptoms, including light sensitivity and double vision. Compared with the mild cluster, the moderate cluster had 5.06-fold higher depression odds (95% CI [2.08-12.31]; p < .001) and the severe cluster 17.17-fold higher odds (95% CI [5.66-52.14]; p < .001). Higher resilience was independently protective (OR = 0.95, 95% CI [0.93-0.96]; p < .001), as was each additional GCS score (OR = 0.20, 95% CI [0.06-0.62]; p = .005). The full model showed excellent discrimination with an AUC of 88%, 95% CI [0.83-0.92].
conclusionsOur data-driven approach shows that distinct post-concussion symptom-severity phenotypes, when integrated with GCS and resilience metrics, yields a robust tool for identifying mTBI survivors at high risks of depression. These findings support early, targeted mental-health screening and lay the groundwork for prospective validation and personalized intervention strategies. CLINICAL TRIAL NUMBER: NCT04243226. Registered on January 20. 2020.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.